Prospective infection surveillance and systematic screening for vancomycin-resistant enterococci in hematologic and oncologic patients - findings of a German tertiary care center.
Vancomycin-resistant enterococci
hematology and oncology
infection
intestinal colonization
screening
surveillance
Journal
Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
31
10
2019
revised:
14
01
2020
accepted:
10
02
2020
pubmed:
25
2
2020
medline:
24
6
2021
entrez:
25
2
2020
Statut:
ppublish
Résumé
Vancomycin-resistant enterococci (VRE) are emerging multidrug-resistant bacteria. They can cause serious nosocomial infections, especially in immunocompromised patients. In this study, we aimed to determine the burden of intestinal VRE colonization and clinically relevant infection in adult hematologic and oncologic patients at a tertiary care clinic in Germany based on prospective infection surveillance and an active screening program. In a 12 month period, 132 of 555 patients had intestinal VRE-colonization (23.8%) and four patients (0.7% of the entire cohort, and 3.0% of those colonized with VRE) developed a nosocomial infection with VRE. The prospective surveillance and active screening for VRE was very useful to determine the true ratio of intestinal colonization to infection and thus helps to shape infection control management.
Identifiants
pubmed: 32092477
pii: S2213-7165(20)30041-2
doi: 10.1016/j.jgar.2020.02.012
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102-105Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.